Compare BioNano Genomics Inc (BNGO) vs Invesco DB Agriculture Fund (DBA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Invesco DB Agriculture Fund — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while Invesco DB Agriculture Fund trades at $27.61. The key difference: Invesco DB Agriculture Fund is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | DBA | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | — |
52-Week High | $4.92 | $28.73 |
52-Week Low | $1.06 | $25.44 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
DBA trades at $27.84, up 0.07% today, with a bullish technical signal from moving averages. The ETF has gained 5% over the past month, outperforming the S&P 500, as agricultural commodities benefit from supply concerns and strong demand. Recent news highlights consolidation near all-time highs, supported by a 3.25% yield and diversified exposure to agricultural futures.
The outlook remains positive due to geopolitical tensions and China's crop purchase pledges, but risks include commodity volatility and management fees. Investors should weigh the ETF's momentum against potential price swings in underlying futures contracts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Invesco DB Agriculture Fund
The index, which is comprised of one or more underlying commodities ("index commodities"), is intended to reflect the agricultural sector. The fund pursues its investment objective by investing in a portfolio of exchange-traded futures.
Read more on DBA →
